COCRYSTAL PHARMA, INC. Increase (Decrease) in Accounts Receivable
COCRYSTAL PHARMA, INC. (COCP) reported Increase (Decrease) in Accounts Receivable of $35.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts receivable for the quarter ending 2021-12-31 was -$6.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts receivable for the quarter ending 2021-09-30 was $6.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts receivable for the quarter ending 2021-06-30 was $0.00.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts receivable for the quarter ending 2021-03-31 was -$556.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts receivable for fiscal 2021 was -$556.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts receivable for fiscal 2020 was -$88.00K, a 113.66% decline from fiscal 2019.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts receivable for fiscal 2019 was $644.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in accounts receivable for fiscal 2017 was -$20.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $35.00K 10-Q · filed 2026-08-13 | ||||||
| 2021-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | -$556.00K 10-K · filed 2023-03-29 | |||
| 2021-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $6.00K derived: sum of 2 quarters · filed 2022-11-14 | -$550.00K 10-Q · filed 2022-11-14 | -$575.00K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$556.00K 10-Q · filed 2022-08-15 | -$581.00K derived: sum of 3 quarters · filed 2022-08-15 | -$592.00K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | -$556.00K 10-Q · filed 2022-05-11 | -$581.00K derived: sum of 2 quarters · filed 2022-05-11 | -$592.00K derived: sum of 3 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$36.00K derived: sum of 2 quarters · filed 2022-03-23 | -$88.00K 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$63.00K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$52.00K 10-Q · filed 2021-08-16 | ||||||
| 2019-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$270.00K derived: sum of 2 quarters · filed 2021-03-17 | -$434.00K derived: sum of 3 quarters · filed 2021-03-17 | $644.00K 10-K · filed 2021-03-17 | |||
| 2019-09-30 | -$146.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$310.00K derived: sum of 2 quarters · filed 2020-11-13 | $768.00K 10-Q · filed 2020-11-13 | ||||
| 2019-06-30 | -$164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $914.00K 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $1.08M 10-Q · filed 2020-05-13 | ||||||
| 2017-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | -$41.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.00K derived: sum of 3 quarters · filed 2018-11-09 | -$20.00K 10-K · filed 2018-03-21 | |||
| 2017-09-30 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | -$21.00K 10-Q · filed 2018-11-09 | -$16.00K derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2017-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $21.00K 10-Q · filed 2017-08-08 | $26.00K derived: sum of 3 quarters · filed 2018-05-10 | -$9.00K derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-03-31 | -$21.00K 10-Q · filed 2018-05-10 | $21.00K 10-Q · filed 2017-05-10 | -$16.00K derived: sum of 2 quarters · filed 2018-05-10 | -$51.00K derived: sum of 3 quarters · filed 2018-05-10 | -$16.00K derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2016-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | -$30.00K derived: sum of 2 quarters · filed 2018-03-21 | $5.00K derived: sum of 3 quarters · filed 2018-03-21 | -$11.00K 10-K · filed 2018-03-21 | $11.00K 10-K · filed 2017-03-31 | ||
| 2016-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | -$16.00K 10-Q · filed 2017-11-08 | $16.00K 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $19.00K 10-Q · filed 2017-08-08 | |||||
| 2016-03-31 | -$16.00K 10-Q · filed 2017-05-10 | ||||||
| 2015-09-30 | $7.00K 10-Q · filed 2016-11-09 | ||||||
| 2013-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | $462.71K derived: sum of 2 quarters · filed 2013-11-18 | $717.78K 10-Q · filed 2013-11-18 | $801.80K derived: sum of 4 quarters · filed 2013-11-18 | |||
| 2013-06-30 | -$926.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | -$670.94K 10-Q · filed 2013-08-15 | -$586.93K derived: sum of 3 quarters · filed 2013-08-15 | -$344.71K derived: sum of 4 quarters · filed 2013-11-18 | |||
| 2013-03-31 | $255.07K 10-Q · filed 2013-05-10 | $339.09K derived: sum of 2 quarters · filed 2013-05-10 | $581.30K derived: sum of 3 quarters · filed 2013-11-18 | $315.63K derived: sum of 4 quarters · filed 2013-11-18 | |||
| 2012-12-31 | $84.01K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $326.23K derived: sum of 2 quarters · filed 2013-11-18 | $60.56K derived: sum of 3 quarters · filed 2013-11-18 | -$461.76K 10-K · filed 2013-04-01 | |||
| 2012-09-30 | $242.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | -$23.46K derived: sum of 2 quarters · filed 2013-11-18 | -$545.78K 10-Q · filed 2013-11-18 | -$496.27K 10-Q · filed 2012-11-14 | $445.58K derived: sum of 4 quarters · filed 2013-11-18 | ||
| 2012-06-30 | -$265.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | -$787.99K 10-Q · filed 2013-08-15 | $203.36K derived: sum of 3 quarters · filed 2013-08-15 | $39.40K derived: sum of 4 quarters · filed 2013-08-15 | |||
| 2012-03-31 | -$522.32K 10-Q · filed 2013-05-10 | $469.03K derived: sum of 2 quarters · filed 2013-05-10 | $305.07K derived: sum of 3 quarters · filed 2013-05-10 | $31.40K derived: sum of 4 quarters · filed 2013-05-10 | |||
| 2011-12-31 | $991.35K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $827.39K derived: sum of 2 quarters · filed 2013-04-01 | $553.72K derived: sum of 3 quarters · filed 2013-04-01 | $560.35K 10-K · filed 2013-04-01 | |||
| 2011-09-30 | -$163.96K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | -$437.63K derived: sum of 2 quarters · filed 2012-11-14 | -$431.00K 10-Q · filed 2012-11-14 | $58.90K derived: sum of 4 quarters · filed 2012-11-14 | |||
| 2011-06-30 | -$273.67K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-09-28 | -$267.04K 10-Q/A · filed 2012-09-28 | $222.86K derived: sum of 3 quarters · filed 2012-10-02 | $378.51K derived: sum of 4 quarters · filed 2012-10-02 | |||
| 2011-03-31 | $6.63K 10-Q/A · filed 2012-10-02 | $496.53K derived: sum of 2 quarters · filed 2012-10-02 | $652.19K derived: sum of 3 quarters · filed 2012-10-02 | ||||
| 2010-12-31 | $489.89K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $645.55K derived: sum of 2 quarters · filed 2012-04-16 | -$650.49K 10-K · filed 2012-04-16 | ||||
| 2010-09-30 | $155.66K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | -$1.14M 10-Q · filed 2011-11-21 | |||||
| 2010-06-30 | -$1.30M 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |